Mr Hunt said hospitalisation numbers were showing promising signs of stabilising after COVID-19 infections had soared during the Omicron wave.
“We’re seeing clear signs that this Omicron wave at least in NSW, Victoria and the ACT has peaked – South Australia had also had some promising signs,” he told reporters.
He said this would help ease pressure on intensive care units.
“We’ve seen a decrease in case numbers significantly and we’ve seen a decrease in hospitalisation numbers of over 100 in Victoria and NSW.”
“That, in turn, will have an impact on ICU and ventilation numbers.”
There are 196 people in intensive care in NSW and 119 people in ICU in Victoria.
Another 24 people died in NSW with 15,091 new infections of COVID-19 – down from 20,324 cases on Sunday.
Victoria, meanwhile, has recorded 17 fatalities and 11,695 cases of the virus – a decrease from 13,091 infections on Sunday.
Queensland reported another 13 deaths and 10,212 cases.
Mr Hunt’s comments come as Australia’s leading advisory group on vaccines gave the final approval to the Novavax vaccine.
The vaccine, the fourth to be approved in Australia for COVID-19, will be rolled out from 21 February.
People wanting to get the Novavax vaccine will need two doses spaced 21 days apart.
Mr Hunt said the protein-based vaccine would provide another option for vaccination – in particular for those facing potential reactions to other vaccines.
Elsewhere, Tasmania has reported 619 new COVID-19 cases, with the number of people being treated in hospital for the virus increasing by one.
Forty-one people in hospital have coronavirus, with 24 of those being treated for unrelated medical conditions, the state health department said.
Seventeen people are being treated for COVID-19, up from 16 reported on Sunday. Three patients are in intensive care.
RATS supplies offered to concession cards holders
Monday marked the beginning of the rollout of free rapid antigen tests to concession card holders across the country.
More than six million Australians who have a concession will be eligible for 10 free rapid tests at pharmacies throughout a three-month period, with a limit of five in one month.
Mr Hunt said 16 million rapid antigen tests were expected to arrive between now and the end of July bolstering supplies of the tests.
“The advice that we have from the pharmacies is that there will be adequate supply going forward,” he said.
However, Pharmacy Guild of Australia president Trent Twomey said supply shortages of the tests meant the rollout would be significantly impacted.
“We don’t have enough today,” he told the Nine Network on Monday.
“There are 6,000 community pharmacies in Australia and 804 pharmacies went live this morning. The majority will simply not be going live.”